Oral Session 3-12A Genomic Mutation in AML

[OS3-12A-6] Analysis for loss of heterozygosity on 13q in acute myeloid leukemia with FLT3-ITD

Masayuki Kanda¹, Satoshi Wakita¹, Haruka Arai¹, Yuho Najima², Kensuke Usuki³, Toshimitsu Ueki⁴, Iekuni Oh⁵, Shinichiro Mori⁶, Nobuhiko Uoshima⁷, Yutaka Kobayashi⁷, Shinichi Kako⁸, Kenji Tajika⁹, Katsuhiro Shono¹⁰, Kensuke Kayamori¹¹, Masao Hagihara¹², Junya Kanda¹³, Hitoji Uchiyama¹⁴, Junya Kuroda¹⁵, Naoyuki Uchida¹⁶, Yasushi Kubota¹⁷, Shinya Kimura¹⁷, Saiko Kurosawa¹⁸, Nana Nakajima¹, Masahiro Sakaguchi¹, Kazuhiko Kakihana², Yoshinobu Kanda^5,9, Kazuteru Ohashi², Takahiro Fukuda¹⁸, Hiroki Yamaguchi¹, Koichi Inokuchi¹ (1.Department of Hematology, Nippon Medical School, Tokyo, Japan, 2.Hematology Division, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan, 3.Department of Hematology, NTT Medical Center Tokyo, Tokyo, Japan, 4.Department of Hematology, Nagano Red Cross Hospital, Nagano, Japan, 5.Division of Hematology, Jichi Medical University, Tochigi, Japan, 6.Hemato-Oncology Department, St Lukes International Hospital, Tokyo, Japan, 7.Department of Hematology, Japanese Red Cross KyotoDaini Hospital, Kyoto, Japan, 8.Hematology Division, Saitama Medical Center, Jichi Medical University, Saitama, Japan, 9.Department of Hematology, Yokohama Minami Kyousai Hospital, Kanagawa, Japan, 10.Department of Hematology, Chiba Aoba Municipal Hospital, Chiba, Japan, 11.Department of Hematology, Chiba University Hospital, Chiba, Japan, 12.Department of Hematology, Eiju General Hopital, Tokyo, Japan, 13.Department of Hematology and Oncology, Kyoto University, Kyoto, Japan, 14.Hematology Division, Japanese Red-Cross Kyoto Daiichi Hospital, Kyoto, Japan, 15.Division of Hematology-and-Oncology, Kyoto Prefectural University of Medicine, Kyoto, Japan, 16.Department of Hematology, Toranomon Hospital, Tokyo, Japan, 17.Division of Hematology, Respiratory and Oncology, Saga University, Saga, Japan, 18.Department of HSCT, National Cancer Center Hospital, Tokyo, Japan)